全文获取类型
收费全文 | 7697篇 |
免费 | 1012篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 1002篇 |
妇产科学 | 56篇 |
基础医学 | 576篇 |
口腔科学 | 85篇 |
临床医学 | 552篇 |
内科学 | 2003篇 |
皮肤病学 | 206篇 |
神经病学 | 151篇 |
特种医学 | 133篇 |
外科学 | 2884篇 |
综合类 | 251篇 |
预防医学 | 181篇 |
眼科学 | 88篇 |
药学 | 252篇 |
中国医学 | 33篇 |
肿瘤学 | 340篇 |
出版年
2023年 | 248篇 |
2022年 | 162篇 |
2021年 | 319篇 |
2020年 | 494篇 |
2019年 | 569篇 |
2018年 | 520篇 |
2017年 | 460篇 |
2016年 | 393篇 |
2015年 | 333篇 |
2014年 | 502篇 |
2013年 | 594篇 |
2012年 | 402篇 |
2011年 | 426篇 |
2010年 | 364篇 |
2009年 | 330篇 |
2008年 | 331篇 |
2007年 | 310篇 |
2006年 | 323篇 |
2005年 | 290篇 |
2004年 | 228篇 |
2003年 | 183篇 |
2002年 | 167篇 |
2001年 | 135篇 |
2000年 | 96篇 |
1999年 | 86篇 |
1998年 | 48篇 |
1997年 | 47篇 |
1996年 | 37篇 |
1995年 | 53篇 |
1994年 | 56篇 |
1993年 | 43篇 |
1992年 | 54篇 |
1991年 | 31篇 |
1990年 | 24篇 |
1989年 | 16篇 |
1988年 | 23篇 |
1987年 | 21篇 |
1986年 | 25篇 |
1985年 | 23篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 15篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1974年 | 2篇 |
排序方式: 共有8829条查询结果,搜索用时 31 毫秒
51.
52.
53.
54.
S.W. Considine N.F. Davis L.C. McLoughlin P. Mohan J.C. Forde R. Power G. Smyth D.M. Little 《The surgeon》2019,17(1):1-5
Introduction
Transplant units are exploring strategies to increase the availability of donor kidneys. The use of en-bloc kidney transplantation (EBKT) from paediatric donors represents one potential solution. We present our long-term experience with paediatric EBKT among adult recipients.Methods
Twenty-three paediatric to adult EBKTs were performed by the Irish National Kidney Transplant Service between 1990 and 2016. The primary outcome variable was long-term en-bloc allograft survival rate. Secondary outcome variables were incidence of allograft thrombosis, incidence of delayed graft function, overall patient survival and serum creatinine at most recent follow-up. Outcomes were compared to single kidney transplant recipients from the same time period.Results
Mean donor age was 1.8 ± 0.97 years (range: 7 months to 3 years). Recipient age was 46 ± 12 years. Mean follow-up was 133 ± 64 months (range: 36–264). Overall graft survival was 100%, 91% and 80% after 1, 5 and 10 years respectively, compared to 92%, 79% and 61% in single kidney transplant recipients (p = 0.04). There were 5 cases of allograft failure, 3 due to death from unrelated causes. Median time to graft failure was 108 months (range: 36–172). Mean serum creatinine was 72.6 ± 21.6 μmol/l after the follow-up period. There were no cases of graft thrombosis or delayed graft function. Overall survival was 96.4%, 88.0%, 76.23% and 50.5% at 1, 5, 10 and 20 years respectively.Conclusion
En-bloc paediatric kidney transplantation is associated with excellent long-term allograft and patient survival and is a feasible strategy for increasing the transplant donor pool in carefully selected recipients. 相似文献55.
目的:研究服用硫唑嘌呤(AZA)中国肾移植患者红细胞(RBC)内活性代谢物6-硫鸟嘌呤核苷酸(6-TGNs)分布特征及影响因素,为临床合理应用嘌呤类药物提供依据。方法:以89例中国肾移植患者为研究对象,关联分析年龄、性别、体质量、AZA剂量和TPMT活性对RBC内6-TGNs浓度的影响,并应用SPSS v20.0软件进行多元线性回归分析。结果:89例中国肾移植患者RBC内6-TGNs浓度呈非正态分布(P<0.000 1),6-TGNs浓度中位数为167.60(四分位间距,108.10~300.80) pmol/8×108 RBC,个体间差异约24.3倍。关联分析显示患者年龄、性别、体质量、TPMT活性对6-TGNs浓度均无显著影响(P>0.05);而AZA剂量与6-TGNs浓度间呈显著正相关性(rs=0.307 1,P<0.01)。多元线性回归分析显示,RBC内6-TGNs浓度与AZA剂量间呈显著正相关(P<0.001),与TPMT活性呈显著负相关(P<0.05)。结论:AZA剂量和RBC内TPMT活性协同影响嘌呤类药物活性代谢物6-TGNs浓度,进而影响该类药物临床疗效和毒性反应。 相似文献
56.
57.
《Revista espa?ola de cardiología》2020,73(11):919-926
Introduction and objectivesThe present report describes the clinical characteristics and outcomes of heart transplants in Spain and updates the data to 2019.MethodsWe describe the clinical characteristics and outcomes of heart transplants performed in Spain in 2019, as well as trends in this procedure from 2010 to 2018.ResultsIn 2019, 300 transplants were performed (8794 since 1984; 2745 between 2010 and 2019). Compared with previous years, the most notable findings were the decreasing rate of urgent transplants (38%), and the consolidation of the type of circulatory support prior to transplant, with an almost complete disappearance of counterpulsation balloon (0.7%), stabilization in the use of extracorporeal membrane oxygenation (9.6%), and an increase in the use of ventricular assist devices (29.0%). Survival from 2016 to 2018 was similar to that from 2013 to 2015 (P = .34). Survival in both these periods was better than that from 2010 to 2012 (P = .002 and P = .01, respectively).ConclusionsHeart transplant activity has remained stable during the last few years, as have outcomes (in terms of survival). There has been a trend to a lower rate of urgent transplants and to a higher use of ventricular assist devices prior to transplant.Full English text available from:www.revespcardiol.org/en 相似文献
58.
59.
60.
《Journal of Radiology Nursing》2022,41(1):33-37
ObjectiveThis study sought to evaluate the effectiveness of diltiazem at achieving a targeted heart rate (HR) of ≤75 bpm in orthotopic heart transplant patients during coronary computed tomography (CT) angiography.MethodsBaseline heart rates were compared to heart rates after diltiazem administration in 25 adult orthotopic heart transplant subjects being monitored by electrocardiogram (ECG) gaiting on a multidetector CT scanner.ResultsThe mean baseline HR of the group was 84.28 ± 11.305 bpm. After diltiazem administration, the mean heart rate of the group at the time of the coronary CT angiography study was 75.32 ± 9.49 bpm. Heart rates decreased in 23 subjects (92%) and the targeted heart rate of ≤75 bpm was observed in 13 subjects (52%).ConclusionDiltiazem administration was associated with a decrease in heart rate, yet reaching the targeted heart rate was limited. Further study regarding diltiazem dosing and its impact is warranted. 相似文献